Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona

DALLAS, Sept. 19, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases (IRDs) and geographic atrophy secondary to macular degeneration, today announced presentations at the 24th Euretina congress...